(123)I-Interleukin-2 uptake in squamous cell carcinoma of the head and neck carcinoma.

作者: David Loose , Alberto Signore , Ludovicus Staelens , Katia Vanden Bulcke , Hubert Vermeersch

DOI: 10.1007/S00259-007-0609-9

关键词:

摘要: Introduction Information obtained on the IL-2 receptor status of tumour infiltrating lymphocytes in patients suffering from squamous cell carcinoma head and neck (SSCHN) before after treatment may lead to a better understanding immunological changes related kinetics induced at level ultimately strategy that allows selection those will benefit therapy. This study set out assess relationship between 123I-IL2 single-photon emission computed tomography (SPECT) findings presence receptors (CD25 staining) tumour-infiltrating as well SCCHN cells SCCHN.

参考文章(29)
Ronald B. Herberman, Bruno Azzarone, Eckhart Weidmann, Jonas T. Johnson, Wen-chang Lin, Manuela Sacchi, Stephane Plaisance, Theresa L. Whiteside, Dae Seog Heo, Satoshi Yasumura, Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ. Cancer Research. ,vol. 52, pp. 5963- 5970 ,(1992)
R B Herberman, H Rabinowich, T L Whiteside, D Vitolo, S Altarac, Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells. Journal of Immunology. ,vol. 149, pp. 340- 349 ,(1992)
Chiara Panetta, Alessio Annovazzi, Francesco Scopinaro, Stephen J. Mather, Calogero D'Alessandria, Daniele Innocenzi, Alberto Signore, Elena Bonanno, Raffaella Barone, Ugo Bottoni, Stefano Calvieri, Marco Chianelli, 99mTc-Interleukin-2 Scintigraphy as a Potential Tool for Evaluating Tumor-Infiltrating Lymphocytes in Melanoma Lesions: A Validation Study The Journal of Nuclear Medicine. ,vol. 45, pp. 1647- 1652 ,(2004)
Manuela Sacchi, Carl H Snyderman, Dae Seog Heo, Jonas T Johnson, Frank d'Amico, Ronald B Herberman, Theresa L Whiteside, None, Local Adoptive Immunotherapy of Human Head and Neck Cancer Xenografts in Nude Mice with Lymphokine-activated Killer Cells and Interleukin 2 Cancer Research. ,vol. 50, pp. 3113- 3118 ,(1990)
Riks A. Maas, Hub F. J. Dullens, Willem Den Otter, Interleukin-2 in cancer treatment: Disappointing or (still) promising? A review Cancer Immunology, Immunotherapy. ,vol. 36, pp. 141- 148 ,(1993) , 10.1007/BF01741084
Mario Airoldi, Antonella De Stefani, Sara Marchionatti, Fulvia Pedani, Pietro Gabriele, Riccardo Ragona, Giorgio Cortesina, Cesare Bumma, Survival in patients with recurrent squamous cell head and neck carcinoma treated with bio-chemotherapy. Head and Neck-journal for The Sciences and Specialties of The Head and Neck. ,vol. 23, pp. 298- 304 ,(2001) , 10.1002/HED.1034
Antonella De Stefani, Guido Forni, Riccardo Ragona, Giovanni Cavallo, Mario Bussi, Antonio Usai, Fausto Badellino, Giorgio Cortesina, Improved survival with perilymphatic interleukin 2 in patients with resectable squamous cell carcinoma of the oral cavity and oropharynx Cancer. ,vol. 95, pp. 90- 97 ,(2002) , 10.1002/CNCR.10654
K. B�heim, H. Denz, C. B�heim, H. Glassl, H. Huber, An immunohistologic study of the distribution and status of activation of head and neck tumor infiltrating leukocytes. European Archives of Oto-rhino-laryngology. ,vol. 244, pp. 127- 132 ,(1987) , 10.1007/BF00458563
Carlos Grande, Jose Luis Firvida, V??ctor Navas, Joaquin Casal, Interleukin-2 for the treatment of solid tumors other than melanoma and renal cell carcinoma. Anti-Cancer Drugs. ,vol. 17, pp. 1- 12 ,(2006) , 10.1097/01.CAD.0000182748.47353.51